phase readout
saveNCT07482605: Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion
NOT_YET_RECRUITINGupdated 5d ago
community read0 votes
Sponsor: Jiangmen Central Hospital. Phase: PHASE2. Conditions: Lung Cancer (NSCLC), Malignant Pleural Effusions (Mpe)- Pleurodesis
view source ↗
comments(0)
5-min edit window · permanent after that